Topic

Humana

A collection of 1087 issues

Getting Lamzede (velmanase alfa-tycv) Covered by Humana in Washington: Complete PA Guide and Appeal Process

Answer Box: Your Fastest Path to Coverage Humana Medicare Advantage requires prior authorization for Lamzede (velmanase alfa-tycv) under the medical benefit. To get approved in Washington: 1. Confirm diagnosis: Submit genetic testing (MAN2B1 variants) or enzyme assay showing alpha-mannosidase deficiency 2. Document medical necessity: Specialist letter detailing non-CNS manifestations, prior
5 min read

How to Get iLink® Corneal Cross-Linking Covered by Humana in California: Complete Guide to Prior Authorization and Appeals

Answer Box: Getting iLink® Covered by Humana in California Yes, Humana generally covers iLink® corneal cross-linking for progressive keratoconus when medical necessity criteria are met. The fastest path to approval: 1) Verify your ophthalmologist and facility are in-network, 2) Submit prior authorization with documented progression over 12 months (≥1.0
6 min read

How to Get Luxturna Covered by Humana in Michigan: Complete Forms, Appeals Guide & Contact Numbers

Answer Box: Getting Luxturna Covered by Humana in Michigan Humana requires prior authorization for Luxturna (voretigene neparvovec-rzyl) for biallelic RPE65 mutation-associated retinal dystrophy. Submit requests through Humana's provider portal or fax completed Medicare medication PA forms to 877-486-2621. Required documentation includes CLIA-certified genetic testing confirming biallelic RPE65 mutations,
7 min read

How to Get Takhzyro (lanadelumab-flyo) Covered by Humana in Pennsylvania: Appeals Guide, Forms & Success Strategies

Answer Box: Getting Takhzyro Covered by Humana in Pennsylvania Yes, Humana Medicare Advantage requires prior authorization for Takhzyro (lanadelumab-flyo) in Pennsylvania. The fastest path to approval: 1) Confirm your HAE diagnosis with documented C1-INH lab abnormalities and attack frequency ≥1 per month, 2) Have your allergist/immunologist submit a complete
6 min read